Scientists have discovered a drug combination that could halt the progression of fibrosis—a condition believed to be responsible for almost half of all deaths—according to a study published in the journal European Urology. Researchers from Anglia Ruskin University, University College London and KU Leuven have spent seven years working on finding the right drug combination